We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Analysis of the Cytomegalovirus Proteome Reveals Unanticipated Complexity

By LabMedica International staff writers
Posted on 05 Dec 2012
Advanced genomic and proteomic analysis techniques have been used for an in-depth study of the proteome of human Cytomegalovirus (HCMV), an incredibly successful pathogen that infects nearly everyone.

The huge 240,000 base pair HCMV genome was sequenced more than 20 years ago, but the viral proteome (the proteins encode by those genes) has not been studied in a comprehensive fashion. More...


Investigators at the University of California, San Francisco (USA) have now obtained much of the missing proteomic data. They used state-of-the-art ribosome profiling and transcript analysis linked to mass spectrometry to experimentally define the HCMV translation products (proteins) and follow their temporal expression. In translation, messenger RNA (mRNA) produced by transcription is decoded by the ribosomes to produce specific polypeptides that will later fold into active proteins.

Ribosome profiling is a technique that uses mRNA to determine what proteins are being translated. It produces a “global snapshot” of all the ribosomes active in the cell at a particular moment. Consequently, this enables researchers to identify the location of translation start sites, their distribution, and the speed of the translating ribosomes. Ribosome profiling derived from the old discovery that the mRNA within a ribosome can be isolated through the use of nucleases that degrade unprotected mRNA regions. This technique analyzes the ratio of multiple specific mRNAs to proteins being synthesized, to provide insight into global gene expression.

Results published in the November 23, 2012, issue of the journal Science revealed hundreds of previously unidentified open reading frames (sites of protein translation), a fraction of which were confirmed by means of mass spectrometry. Many of these open reading frames were found to encode for exceptionally short protein sequences (fewer than 100 amino acids), and some of the newly identified open reading frames were sequestered inside other open reading frames.

These results unveiled an unanticipated complexity to the HCMV coding capacity and illustrated the role of the regulated use of alternative transcript start sites in enabling tight temporal control of HCMV protein expression and allowing multiple distinct polypeptides to be generated from a single genomic locus.

"The genome of a virus is just a starting point," said senior author Dr. Jonathan Weissman, professor of cellular and molecular pharmacology and of biochemistry and biophysics at the University of California, San Francisco. "Understanding what proteins are encoded by that genome allows us to start thinking about what the virus does and how we can interfere with it… Each of the proteins we have identified has the potential to tell us how this virus is manipulating its host cell."

Related Links:
University of California, San Francisco


Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Online QC Software
Acusera 24•7
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group
Steam Sterilizer
Hi Vac II Line
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The approach supports myocardial infarction diagnosis in resource-limited settings by reducing delays between clinical suspicion and biochemical confirmation (Image Credit: Adobe Stock)

Portable Troponin Assay Brings Heart Attack Diagnosis Closer to Patients

Timely confirmation of myocardial infarction often depends on laboratory testing that may not be immediately available at the point of care. This gap between clinical suspicion and definitive evidence... Read more

Molecular Diagnostics

view channel
Image: The two new tests are used with the LightCycler 480 and LightCycler PRO instruments (Photo courtesy of Roche)

New PCR Assays Expand Cyclospora Testing for Outbreak Surveillance

Cyclospora cayetanensis, a food- and waterborne intestinal parasite, can cause prolonged diarrhea, fatigue, and abdominal cramping, placing added strain on urgent care and emergency departments during outbreaks.... Read more

Immunology

view channel
Image: Graphical Abstract (Morgane Fournier et al., Cell (2026). DOI: 10.1016/j.cell.2026.04.013)

Study Reveals Immune Mechanism Driving Severe COVID-19 Progression

Severe COVID-19 has highlighted gaps in understanding of early antiviral responses, particularly why some patients deteriorate despite timely care. Type I interferons are central to host defense, yet their... Read more

Microbiology

view channel
Image: An innovative countywide program in Taiwan combines risk-based screening with decentralized community care to improve hepatitis C detection and treatment (Image Credit: iStock)

Precision Screening Helps Close Hepatitis C Diagnosis and Treatment Gaps

Hepatitis C remains a leading cause of cirrhosis and liver cancer, yet many infections go undiagnosed or untreated because health systems fail to reach those at greatest risk. Although highly effective... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.